
CENCORA INC
CORNYSETrading Snapshot
- Day Range
- $96.27 β $99.15
- 52-Week Range
- $244.82 β $377.54
- Volume
- $3.20B
- Avg Volume
- $3.93B
- Shares Outstanding
- 194.6M
- Next Earnings
- Sep 14, 2026
Fundamentals Snapshot
- Annual Revenue
- $321.33B
- Last Q Revenue
- $84.75B
- P/E Ratio
- 23.6
- P/S Ratio
- 0.2x
- EPS (TTM)
- $13.45
- Dividend Yield
- 0.75%
Why Investors Own COR
- βHigh-growth profile β revenue up +16.6% YoY with expanding US Equity exposure.
- βHealthy economics β 26% gross margin and 15% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CENCORA INC
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
CENCORA INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift COR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CENCORA INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.